Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CERS Cerus	$1.50 -3.8%	$1.35	$1.12 ▼ $2.54	$294.39M	1.56	1.33 million shs	388,973 shs
KIDS OrthoPediatrics	$22.47 +1.5%	$21.49	$19.52 ▼ $35.99	$545.96M	1.1	198,718 shs	90,392 shs
LMAT LeMaitre Vascular	$84.41 +0.7%	$83.18	$71.42 ▼ $109.58	$1.91B	0.82	169,905 shs	75,102 shs
SIBN SiBone	$18.46 +0.2%	$17.82	$11.70 ▼ $20.05	$787.09M	0.93	394,567 shs	288,621 shs
TCMD Tactile Systems Technology	$10.35 +2.2%	$10.49	$8.61 ▼ $21.10	$235.51M	0.95	256,830 shs	124,870 shs

20 Stocks to Sell Now

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CERS Cerus	0.00%	+5.63%	+4.17%	+20.97%	-12.79%
KIDS OrthoPediatrics	0.00%	+5.12%	+11.66%	-1.04%	-24.97%
LMAT LeMaitre Vascular	0.00%	+2.23%	+2.25%	+5.80%	+3.83%
SIBN SiBone	0.00%	+0.16%	-0.16%	+37.05%	+41.56%
TCMD Tactile Systems Technology	0.00%	+0.10%	+2.07%	-21.53%	-9.45%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CERS Cerus	3.3683 of 5 stars	3.5	4.0	0.0	0.0	3.4	1.7	0.6
KIDS OrthoPediatrics	4.1474 of 5 stars	3.4	2.0	0.0	3.9	1.3	3.3	0.6
LMAT LeMaitre Vascular	2.716 of 5 stars	2.2	1.0	3.3	0.0	2.6	2.5	1.3
SIBN SiBone	4.1717 of 5 stars	2.5	5.0	0.0	3.3	2.7	2.5	0.6
TCMD Tactile Systems Technology	3.1279 of 5 stars	3.0	1.0	0.0	0.0	1.1	2.5	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CERS Cerus	3.00	Buy	$3.50	133.33% Upside
KIDS OrthoPediatrics	2.83	Moderate Buy	$35.83	59.51% Upside
LMAT LeMaitre Vascular	2.33	Hold	$97.83	15.90% Upside
SIBN SiBone	3.00	Buy	$22.50	21.89% Upside
TCMD Tactile Systems Technology	2.00	Hold	$16.00	54.59% Upside

Current Analyst Ratings Breakdown

Latest LMAT, TCMD, CERS, SIBN, and KIDS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
5/7/2025	TCMD Tactile Systems Technology	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
5/6/2025	SIBN SiBone	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$20.00 ➝ $22.00
5/6/2025	SIBN SiBone	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$25.00 ➝ $25.00
5/6/2025	SIBN SiBone	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$24.00 ➝ $24.00
5/6/2025	TCMD Tactile Systems Technology	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$25.00 ➝ $14.00
4/11/2025	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$26.00 ➝ $24.00
4/9/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/7/2025	KIDS OrthoPediatrics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$37.00

(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CERS Cerus	$180.27M	1.59	N/A	N/A	$0.31 per share	4.84
KIDS OrthoPediatrics	$204.73M	2.67	N/A	N/A	$14.64 per share	1.53
LMAT LeMaitre Vascular	$219.86M	8.67	$2.39 per share	35.33	$15.00 per share	5.63
SIBN SiBone	$167.18M	4.71	N/A	N/A	$3.98 per share	4.64
TCMD Tactile Systems Technology	$292.98M	0.82	$1.11 per share	9.36	$9.03 per share	1.15

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CERS Cerus	-$20.92M	-$0.10	N/A	N/A	N/A	-10.23%	-34.81%	-9.68%	7/30/2025 (Estimated)
KIDS OrthoPediatrics	-$37.82M	-$1.75	N/A	N/A	N/A	-19.15%	-7.03%	-5.45%	8/4/2025 (Estimated)
LMAT LeMaitre Vascular	$44.04M	$1.98	42.63	38.90	2.23	19.96%	13.53%	9.78%	7/30/2025 (Estimated)
SIBN SiBone	-$30.91M	-$0.64	N/A	N/A	N/A	-15.03%	-16.00%	-11.69%	8/4/2025 (Estimated)
TCMD Tactile Systems Technology	$16.96M	$0.66	15.68	12.32	N/A	5.52%	8.41%	6.10%	8/4/2025 (Estimated)

Latest LMAT, TCMD, CERS, SIBN, and KIDS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million
5/5/2025	Q1 2025	SIBN SiBone	-$0.24	-$0.15	+$0.09	-$0.15	$45.13 million	$47.29 million
5/5/2025	Q1 2025	TCMD Tactile Systems Technology	-$0.07	-$0.13	-$0.06	-$0.13	$63.48 million	$61.27 million
5/1/2025	Q1 2025	CERS Cerus	-$0.05	-$0.04	+$0.01	-$0.04	$47.44 million	$43.24 million
5/1/2025	Q1 2025	LMAT LeMaitre Vascular	$0.50	$0.48	-$0.02	$0.48	$57.61 million	$59.87 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CERS Cerus	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
LMAT LeMaitre Vascular	$0.80	0.95%	N/A	40.40%	14 Years
SIBN SiBone	N/A	N/A	N/A	N/A	N/A
TCMD Tactile Systems Technology	N/A	N/A	N/A	N/A	N/A

Latest LMAT, TCMD, CERS, SIBN, and KIDS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/29/2025	LMAT LeMaitre Vascular	quarterly	$0.20	1%	5/15/2025	5/15/2025	5/29/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CERS Cerus	1.15	2.32	1.63
KIDS OrthoPediatrics	0.21	6.19	2.99
LMAT LeMaitre Vascular	0.48	16.49	13.83
SIBN SiBone	0.21	8.53	7.26
TCMD Tactile Systems Technology	0.11	4.52	3.99

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CERS Cerus	78.37%
KIDS OrthoPediatrics	69.05%
LMAT LeMaitre Vascular	84.64%
SIBN SiBone	98.11%
TCMD Tactile Systems Technology	83.43%

Insider Ownership

Company	Insider Ownership
CERS Cerus	5.60%
KIDS OrthoPediatrics	32.70%
LMAT LeMaitre Vascular	9.50%
SIBN SiBone	4.00%
TCMD Tactile Systems Technology	2.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CERS Cerus	290	191.16 million	180.46 million	Optionable
KIDS OrthoPediatrics	200	24.29 million	16.35 million	Optionable
LMAT LeMaitre Vascular	490	22.59 million	20.45 million	Optionable
SIBN SiBone	350	42.62 million	40.91 million	Optionable
TCMD Tactile Systems Technology	1,037	23.25 million	22.67 million	Optionable

LMAT, TCMD, CERS, SIBN, and KIDS Headlines

Recent News About These Companies

TCMD Tactile Systems Technology, Inc. - Seeking Alpha

July 2 at 5:19 PM | seekingalpha.com

Tactile Systems Technology (NASDAQ:TCMD) investors are sitting on a loss of 76% if they invested five years ago

June 23, 2025 | finance.yahoo.com

Two Sigma Investments LP Sells 31,793 Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD)

June 9, 2025 | marketbeat.com

New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors

June 3, 2025 | globenewswire.com

Tactile Medical to Present at Upcoming Investor Conferences in June

May 20, 2025 | globenewswire.com

Tactile Systems Technology, Inc. (NASDAQ:TCMD) CFO Sells $29,034.74 in Stock

May 15, 2025 | insidertrades.com

Tactile Systems Technology's (NASDAQ:TCMD) Soft Earnings Don't Show The Whole Picture

May 13, 2025 | finance.yahoo.com

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Director Sells $31,911.00 in Stock

May 10, 2025 | insidertrades.com

Piper Sandler Downgrades Tactile Systems Technology (TCMD)

May 8, 2025 | msn.com

Analysts Have Been Trimming Their Tactile Systems Technology, Inc. (NASDAQ:TCMD) Price Target After Its Latest Report

May 7, 2025 | finance.yahoo.com

Why Tactile Systems Technology, Inc.’s (TCMD) Stock Is Down 33.21%

May 6, 2025 | aaii.comA

Tactile Systems stock tumbles after Q1 miss

May 6, 2025 | investing.com

Tactile Systems downgraded to Neutral from Overweight at Piper Sandler

May 6, 2025 | msn.com

Tactile Systems Technology, Inc. (TCMD) Q1 2025 Earnings Call Transcript

May 5, 2025 | seekingalpha.com

With 81% institutional ownership, Tactile Systems Technology, Inc. (NASDAQ:TCMD) is a favorite amongst the big guns

May 5, 2025 | uk.finance.yahoo.com

Tactile Systems Technology (TCMD) Reports Q1 Loss, Lags Revenue Estimates

May 5, 2025 | zacks.com

Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results

May 5, 2025 | globenewswire.com

What To Expect From Tactile Systems Technology Inc (TCMD) Q1 2025 Earnings

May 3, 2025 | finance.yahoo.com

Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025

April 21, 2025 | globenewswire.com

Tactile Systems Technology: Interesting Devices Company, Need More Clarity

April 7, 2025 | seekingalpha.com

The Returns At Tactile Systems Technology (NASDAQ:TCMD) Aren't Growing

March 18, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMAT, TCMD, CERS, SIBN, and KIDS Company Descriptions

Cerus NASDAQ:CERS

$1.50 -0.06 (-3.85%)

Closing price 07/3/2025 03:54 PM Eastern

Extended Trading

$1.53 +0.03 (+2.00%)

As of 07/3/2025 04:24 PM Eastern

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.

OrthoPediatrics NASDAQ:KIDS

$22.46 +0.33 (+1.47%)

As of 07/3/2025 03:24 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

LeMaitre Vascular NASDAQ:LMAT

$84.41 +0.56 (+0.67%)

Closing price 07/3/2025 01:44 PM Eastern

Extended Trading

$84.41 0.00 (0.00%)

As of 07/3/2025 04:20 PM Eastern

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

SiBone NASDAQ:SIBN

$18.46 +0.03 (+0.16%)

As of 07/3/2025 01:04 PM Eastern

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Tactile Systems Technology NASDAQ:TCMD

$10.35 +0.22 (+2.17%)

Closing price 07/3/2025 03:34 PM Eastern

Extended Trading

$10.26 -0.09 (-0.87%)

As of 07/3/2025 04:52 PM Eastern

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time